Finally, we stratified BC by high or low expression of all three cytokines, and high expression of CSF2, CXCL10, and CCL2 predicted a better distant metastasis-free survival and overall survival (OS) for ER− BC patients (Fig. 5d, e). This evidence concerns the gene CCL2 and breast cancer.